Back to top

Acurx (ACXP) Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing

Acurx (ACXP) Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Acurx Pharmaceuticals, Inc. (ACXP)